It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Endovascular treatment of strokes caused by large vessel occlusion enables the histopathological investigation of the retrieved embolus, possibly providing a novel opportunity to contribute to the diagnostic workup of etiology and to define secondary prevention measures in strokes with uncertain genesis. We aimed to develop a classification rule based on pathophysiological considerations and adjustment to reference thrombi for distinction between cardiac and arteriosclerotic emboli and to validate this classification rule on a patient cohort. From 125 patients with stroke due to large vessel occlusion and thrombectomy, 82 patients with known etiology (55 cardioembolic and 27 arterioembolic strokes) were included. The corresponding emboli were histologically evaluated by two raters blinded to the etiology of stroke by means of a novel classification rule. Presumed etiology and classification results were compared. Agreement concerning cardiac emboli was 72.2% (95% CI: 58.4–83.5) for rater I and 78.2% (95% CI: 65.0–88.2) for rater II. Agreement concerning arteriosclerotic emboli was 70.4% (95% CI: 49.8–86.3) for rater I and 74.1% (95% CI: 53.7–88.9) for rater II. Overall agreement reached 71.6% (95% CI: 60.5–81.1) for rater I and 76.8% (95% CI: 66.2–85.4) for rater II. Within the limits of generally restricted accuracy of histological evaluations, the classification rule differentiates between cardiac and arteriosclerotic emboli of acute ischemic stroke patients. Further improvement is needed to provide valuable complementary data for stroke etiology workup.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Justus-Liebig-University Gießen, Department of Neurology, Gießen, Germany (GRID:grid.8664.c) (ISNI:0000 0001 2165 8627)
2 Department of Neuroradiology, Kaiserslautern, Germany (GRID:grid.8664.c)
3 University of Lübeck and University Hospital Schleswig-Holstein, Institute of Pathology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)
4 Research Center Borstel - Leibniz Lung Center, Borstel, Germany (GRID:grid.418187.3) (ISNI:0000 0004 0493 9170)
5 University of Lübeck, Institute of Medical Biometry and Statistics, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)
6 Sana Kliniken Lübeck GmbH, Department of Neurology, Lübeck, Germany (GRID:grid.4562.5)
7 University of Lübeck, Department of Neurology and Center of Brain, Behaviour and Metabolism, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)